If a drug is approved via this expedited pathway, the follow…

If a drug is approved via this expedited pathway, the following will be included in the Indication section of the approved labeling: “This indication is approved under ___________________, based on . Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.”